MBC BioLabs, in collaboration with AbbVie, is pleased to launch the MBC BioLabs Diversity Golden Ticket program, an award designed to support under-represented biotech entrepreneurs using innovative science to deliver solutions for human health. The award provides free lab space and access to state-of-the-art research equipment, professional support staff, conference rooms, and a vibrant, collaborative community to support the sharing of ideas and expertise with other exciting life science companies.

The awardees are

Olfera and Opal Therapeutics

We cannot wait for these amazing companies to join our growing community!

Olfera unlocks the olfactory system’s potential for brain disease treatment.

Opal Therapeutics is at the forefront of drug discovery for uterine disorders, focusing on fibroids and endometriosis. The company aims to address the unmet need for non-surgical therapies and enhance women’s health and well-being in gynecology and reproductive medicine.